“Two-phase”的搜索结果，显示 181-190 项，共有 7528 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study includes 2 parts; step-up dose optimization (Part 1) and dose ... This phase 1b trial is an open-label study designed to assess the safety ...

2. 诊断与治疗 - 妙佑医疗国际

   At this stage, only one lymph node region or one site outside of the lymph nodes is affected. Stage 2 diffuse large B-cell lymphoma. Stage 2 involves two or ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part two of this study is to evaluate safety and ... In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken ...

5. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen ...

6. 血液科- 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part two of this study is to evaluate safety and ... In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken ...

8. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to investigate outcomes for all patients with upper or lower extremity lymphedema with lymph node transfer in a two stage ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...